Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
May 23 2008 - 7:00PM
PR Newswire (US)
SAN DIEGO, May 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will Web cast its Annual Meeting of Stockholders
on Friday, May 30, 2008 at 11:00 a.m. PT from the company's
corporate headquarters in San Diego, CA. Following the Annual
Meeting, Daniel M. Bradbury, President and Chief Executive Officer
of Amylin Pharmaceuticals, will be providing a corporate overview.
The live presentation will be Web cast, and a recording will be
made available following the event. The Web cast and recording will
be accessible through Amylin's corporate Web site, located at
http://www.amylin.com/. To access the live Web cast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two first-
in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate)
injection and BYETTA(R) (exenatide) injection. Amylin's research
and development activities leverage the company's expertise in
metabolism to develop potential therapies to treat diabetes and
obesity. Amylin is headquartered in San Diego, California with over
1,900 employees nationwide. Further information on Amylin
Pharmaceuticals is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Michael York, Senior
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 8602 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024